IN VITRO SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO LUMEFANTRINE AND ANALYSIS OF POLYMOPHYSIMS IN PFMDR-1 GENE ISOLATES FROM ABIDJAN (CÔTE D'IVOIRE)
暂无分享,去创建一个
[1] N. Waters,et al. The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011 , 2013, PloS one.
[2] I. Arzika,et al. Ex Vivo Responses of Plasmodium falciparum Clinical Isolates to Conventional and New Antimalarial Drugs in Niger , 2013, Antimicrobial Agents and Chemotherapy.
[3] M. Petzold,et al. Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania , 2013, Malaria Journal.
[4] A. Nzila,et al. Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine. , 2012, The Journal of antimicrobial chemotherapy.
[5] A. Feller,et al. Genome Wide Adaptations of Plasmodium falciparum in Response to Lumefantrine Selective Drug Pressure , 2012, PloS one.
[6] C. Rogier,et al. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum , 2012, Malaria Journal.
[7] C. Rogier,et al. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs , 2011, Malaria Journal.
[8] B. Pradines,et al. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia , 2011, Malaria Journal.
[9] M. Ranjit,et al. Sequence analysis of coding DNA fragments of pfcrt and pfmdr-1 genes in Plasmodium falciparum isolates from Odisha, India. , 2011, Memorias do Instituto Oswaldo Cruz.
[10] S. Ward,et al. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. , 2010, The American journal of tropical medicine and hygiene.
[11] Teferi Eshetu,et al. Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia , 2010, Malaria Journal.
[12] D. Joseph,et al. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine. , 2010, Tanzania journal of health research.
[13] A. Djaman,et al. In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire). , 2010, African health sciences.
[14] C. Rogier,et al. La résistance aux antipaludiques , 2010 .
[15] P. Rosenthal,et al. In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda , 2010, Antimicrobial Agents and Chemotherapy.
[16] C. Sutherland,et al. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates , 2010, Malaria Journal.
[17] P. Rosenthal,et al. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial , 2009, BMJ : British Medical Journal.
[18] J. Chevillotte. Recommandations sanitaires pour les voyageurs , 2009 .
[19] P. Kremsner,et al. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria , 2007, Malaria Journal.
[20] C. Dolea,et al. World Health Organization , 1949, International Organization.